Expecting a 15-17% Swing on DTIL as the stock rounds off from it's previous $12.50 Breakout Consolidation. It seems as though profit-taking has completed and the stock is moving higher in the pre-market session to solidify the swing trade. We have been watching the stock for the past few days and the Buying Volume has spiked over the course of that time period. In...
Putting this one out there for those that are interested. I am not advising one way or the other.
Off 18% at the time of this note. Hit a prior area of consolidation. Likely moving through this level and on to the next lower support line before a reversal.
LONG touch the resistance and have the potential to rise.
DTIL has been gaining of late inside of the small BLUE rising channel. As unassuming as it may look, this 3 month uptrend has already broken through a couple nasty resistance lines: the upper boundary of the RED falling channel, and the horizontal resistance of the BLACK rising triangle. If DTIL can trade above the 200 dma (4% above current price), then it could...
Alert set for break above $9.10 of possible long entry . 200ma and .236 Fib resistance to breakout Indicators bullish with room to run much higher Company Profile Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics...
This stock is high risk but carries a lot of potential. The structure is a textbook play.
DTIL is now trading above its supporting moving averages. The MACD is trending higher and Volume is coming up. the 200 sma looms above as resistance but I like this one.
Hi, today we are going to talk about Precision BioSciences and its current landscape. Precision BioSciences, the genome editing company has received attention lately as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that...
Precision Biosciences is a cancer and genetic therapeutic company, based in North Carolina that went public this past March at 18.00 a share. The "3 Box Technical Indicator" shown here, shows DTIL has made a Very Powerful " V Bottom Breakout" this past week. When you purchase a stock,always look for "over performance",as a key criteria to ownership. Precision...
IPO U Base breakout William O'neil Style breakout
When a stock gets this much Analysts attention in the one day we take notice. With the average price target of $24 this has huge upside potential. It is a name that requires much more research but we are very interested by these upgrades.